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Abstract: The aim of this study was to examine racial differences in long-term survival 
among hemodialysis patients after coronary artery bypass grafting (CABG). To our 
knowledge this has not been previously addressed in the literature. Black and white 
hemodialysis patients undergoing first-time, isolated CABG procedures between 1992 and 
2011 were compared. Survival probabilities were computed using the Kaplan-Meier 
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product-limit method and stratified by race. Hazard ratios (HR) and 95% confidence 
intervals (CI) were computed using a Cox regression model. A total of 207 (2%) patients 
were on hemodialysis at the time of CABG. White (n = 80) hemodialysis patients had 
significantly decreased 5-year survival compared with black (n = 127) patients (adjusted 
HR = 1.9, 95% CI = 1.2–2.8). Our finding provides useful outcome information for 
surgeons, primary care providers, and their patients. 
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1. Introduction 
Chronic kidney disease (CKD) and the progression to end-stage renal disease (ESRD) are 
associated with increased cardiovascular-related mortality [1]. Hemodialysis (HD) patients have an 
increased prevalence of risk factors for cardiovascular disease and are more likely to have multi-vessel 
coronary artery disease (CAD) [2]. HD patients also have been identified as a high-risk surgical group 
due to their decreased long-term survival after cardiac surgery [3–5]. 
Survival paradoxes are well documented among cardiovascular and HD patients and “describe the 
association of certain risk factors with negative outcomes in the general population and the opposite 
effect in certain subpopulations and vice versa” [6]. Conventional cardiovascular risk factors such as 
black race, hypercholesterolemia, hypertension, and obesity are associated with increased survival 
among HD dialysis [7]. The rationale for the current study was to determine if similar reverse 
epidemiologic findings are observed among black HD patients undergoing isolated CABG in our rural, 
racially dichotomous population. 
2. Experimental Section  
Details of the study database have been previously described and are summarized below [8–10]. 
2.1. Study Design 
This was a retrospective cohort study of 207 HD patients undergoing first-time, isolated CABG at 
the East Carolina Heart Institute between 1992 and 2011. Demographic data, comorbid conditions, 
CAD severity, and surgical data were collected at the time of surgery. Only black and white patients 
were included to minimize the potential for residual confounding (~1% other races). Racial identity 
was self-reported. HD patients who died during the in-hospital postoperative period were excluded to 
limit the influence of short-term survival on long-term outcomes. Of these, 10 were black (mean  
age = 65 ± 12, 50% male) and 8 were white (mean age = 65 ± 10, 63% male). The study was approved 
by the Institutional Review Board at the Brody School of Medicine, East Carolina University.  
  
Int. J. Environ. Res. Public Health 2013, 10 4177 
 
 
2.2. Definitions 
HD was defined as patients with ESRD requiring dialysis preoperatively. Non-elective procedures 
included urgent, emergent, and salvage operations. Long-term mortality was defined as any cause of 
death occurring postoperatively. CAD severity was defined by the number of diseased vessels (1, 2,  
or 3) with at least 50% stenosis and confirmed by angiography before surgery.  
2.3. Setting 
The East Carolina Heart Institute is a 120-bed cardiovascular hospital located in the center of 
eastern North Carolina, a rural region with a large black population. The institute is the largest  
stand-alone, tertiary referral hospital focusing on cardiovascular care in the state of North Carolina. 
Cardiovascular disease is the number one cause of death in North Carolina with an unequal burden 
occurring in eastern North Carolina [11]. The institute is a population-based tertiary referral center. 
Nearly all patients treated at the East Carolina Heart Institute live and remain within a 150-mile radius 
of the medical center. 
2.4. Data Collection and Follow-up 
The primary sources of data extraction were the Society of Thoracic Surgeons (STS) Adult Cardiac 
Surgery Database and the electronic medical record at the Brody School of Medicine. Cardiovascular 
surgery information at our facility has been reported to the STS since 1989. Data quality and  
cross-field validation are routinely performed by the Epidemiology and Outcomes Research Unit at the 
East Carolina Heart Institute. An electronic medical record was introduced at the Brody School of 
Medicine in 1997. Records from 1989 to 1997 were retrospectively scanned into the electronic medical 
record. Local and regional clinics were consolidated under a single electronic medical record in  
2005 which allowed for efficient patient follow-up. The electronic medical record system applies 
multiple logic comparisons to reliably reduce mismatching of patient data across clinics and follow-up 
visits. The STS database is linked to the electronic medical record through a unique patient medical 
record number.  
Given the relatively stable patient catchment area for the East Carolina Heart Institute, most deaths 
are determined through the regional medical center electronic medical record system, follow-up 
letters/phone calls (primary care providers, patients), death certificates from county registrars, and/or 
obituary notices. Approximately 10% of deaths were exclusively determined by linkage with the 
National Death Index. The National Death Index also was used to validate death information captured 
in our electronic medical record. Linkage with the National Death Index was based on a multiple 
criteria, deterministic matching algorithm [12]. In our database, less than 5% of validated deaths failed 
to correctly match with the National Death Index. 
2.5. Statistical Analysis 
Categorical variables were reported as frequency and percentage while continuous variables were 
reported as mean ± standard deviation, median, and range. Variables not previously categorized were 
divided into quartiles prior to statistical analysis. Quartile categorization is advantageous because it 
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limits the influence of outliers and allows for the assessment of trend across categories. Follow-up time 
was measured from the date of surgery to the date of death or censoring. Survival probabilities were 
computed using the Kaplan-Meier product-limit method. The log-rank test was used to compare 
survival between black and white patients. Cox proportional hazard regression models were used to 
compute hazard ratios (HR) and 95% confidence intervals (CI) for long-term mortality. The initial 
multivariable models included variables that have been previously reported to be associated with 
cardiovascular-related mortality, regardless of their statistical significance in our dataset. These 
included age, sex, hypertension, CAD severity, heart failure, and prior stroke [8]. The post-hoc 
addition of other variables into the model was performed in a pairwise fashion. The test statistic of 
Grambsch and Therneau was used to check the proportional hazards assumption [13]. Survival was 
truncated at 5 years due to the sparseness of events beyond this time point. Statistical significance for 
categorical variables was tested using the Fisher’s Exact Test and the Deuchler-Wilcoxon Procedure 
for continuous variables. PTrend for decreasing or increasing HRs across levels of continuous  
variables was computed using a likelihood ratio test. There were no missing values in this study.  
SAS Version 9.3 (Cary, NC, USA) was used for this analysis. Statistical significance was defined as  
p < 0.05. 
3. Results and Discussion 
3.1. Results 
A total of 13,453 patients underwent isolated CABG between 1992 and 2011. Of these,  
207 (2%) patients were on HD at the time of surgery (Table 1). There were 127 (61%) black and  
80 (39%) white HD patients (Table 1). A greater percentage of black patients (49%) were female  
than white patients (34%) (p < 0.05). Median follow-up for HD patients was 2.5 years. A greater 
percentage of white than black HD patients (43% vs. 28%) were on preoperative anti-platelet therapy 
(Table 2). No statistically significant differences were observed between black and white HD patients 
for postoperative complications (Table 3). 
Table 1. Patient characteristics (N = 207). 
Characteristic 
Black White 
Univariable 
HR (95% CI) 
n (%) 1, 3, 5 Year 
Survival 
n (%) 1, 3, 5 Year 
Survival 
Overall 127 (61) 85, 62, 44 80 (39) 78, 48, 30 1.6 (1.1–2.3) ‡ 
Age (Years) 
Q1 (≤53) 
Q2 (>53–60) 
Q3 (>60–66) 
Q4 (>66) 
Mean ± SD  
Median (Range) 
 
38 (30) 
35 (28) 
25 (20) 
29 (23) 
59 ± 9.7 
60 (35–80) 
 
92, 74, 67 
88, 66, 30 
83, 68, 54 
72, 39, 20 
 
21 (26) 
14 (18) 
23 (29) 
22 (28)  
60 ± 9.2 
62 (39–77) 
 
61, 25, 20 
100, 85, 53 
87, 51, 32 
73, 44, 23 
 
 
1.0 Referent 
1.04 (0.60–1.8) 
1.1 (0.64–2.0) 
1.9 (1.2–3.2) 
PTrend = 0.012 
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Table 1. Cont. 
Characteristic 
Black White 
Univariable 
HR (95% CI) n (%) 
1, 3, 5 Year 
Survival 
n (%) 
1, 3, 5 Year 
Survival 
Sex 
Male 
Female 
 
65 (51) 
62 (49) 
 
92, 72, 54 
77, 52, 33 
 
53 (66) 
27 (34) * 
 
81, 53, 35 
73, 38, 21 
 
1.0 Referent 
1.6 (1.1–2.3) 
BMI (kg/m2) 
Obese (≥30) 
Overweight (25–29.9) 
Normal (18.5–24.9) 
Underweight (<18.5) 
Mean ± SD 
Median (Range) 
 
50 (39) 
48 (38) 
27 (21) 
2 (2) 
29 ± 5.8 
28 (18–49)  
 
83, 67, 41 
89, 63, 46 
80, 53, 44 
50, 50 † 
 
23 (29) 
32 (40) 
22 (28) 
3 (4) 
27 ± 5.2 
27 (17–41)  
 
87, 75, 58 
81, 47, 30 
73, 27, 5 
33, 33, 33 
 
1.0 Referent 
1.3 (0.81–2.1) 
1.9 (1.2–3.1) 
2.1 (0.64–6.9) 
PTrend = 0.0091 
CAD Severity 
1 Vessel 
2 Vessel 
3 Vessel 
 
8 (6) 
37 (29) 
82 (65) 
 
100, 73, 55 
86, 61, 44 
82, 61, 43 
 
2 (3) 
27 (34) 
51 (64) 
 
100, 100, 100 
77, 61, 48 
78, 38, 16 
 
1.0 Referent 
2.0 (0.61–6.5) 
2.6 (0.83–8.4) 
PTrend = 0.035 
Non-Elective 
No 
Yes 
 
58 (46) 
69 (54) 
 
89, 64, 49 
81, 61, 40 
 
33 (41) 
47 (59) 
 
81, 63, 51 
76, 38, 16 
 
1.0 Referent 
1.6 (1.1–2.4) 
Hypertension 
No 
Yes 
 
11 (9) 
116 (91) 
 
73, 45, 27 
86, 64, 46 
 
7 (9) 
73 (91) 
 
83, 33, 17 
78, 49, 31 
 
1.0 Referent 
0.61 (0.34–1.1) 
Diabetes 
No 
Yes 
 
54 (43) 
73 (57) 
 
88, 60, 45 
82, 63, 42 
 
27 (34) 
53 (66) 
 
78, 44, 28 
79, 50, 31 
 
1.0 Referent 
1.0 (0.71–1.5) 
Heart Failure  
No 
Yes 
 
72 (57) 
55 (43) 
 
93, 69, 49 
73, 53, 37 
 
46 (58) 
34 (42) 
 
82, 51, 32 
73, 44, 27 
 
1.0 Referent 
1.5 (1.1–2.3) 
Prior Stroke 
No 
Yes 
 
105 (83) 
22 (17) 
 
87, 64, 49 
71, 51, 19 
 
71 (89) 
9 (11) 
 
81, 51, 33 
53, 20 † 
 
1.0 Referent 
2.1 (1.3-3.4) 
Previous MI 
No 
Yes 
 
71 (56) 
56 (44) 
 
86, 65, 49 
83, 58, 36 
 
42 (53) 
38 (47) 
 
88, 47, 30 
68, 49, 30 
 
1.0 Referent 
1.2 (0.85–1.8) 
* p < 0.05 (comparison of black vs. white patients), Fisher’s Exact (Categorical Variables), Deuchler-Wilcoxon Test 
(Continuous Variables); † Last follow-up not reached; ‡ Black vs. White. BMI = body mass index; CAD = coronary artery 
disease; CI = confidence interval; HR = hazard ratio; Q1 = quartile 1; Q2 = quartile 2; Q3 = quartile 3; Q4 = quartile 4; 
MI = myocardial infarction; SD = standard deviation. 
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Table 2. Preoperative medications (N = 207). 
Medication Black n (%) White n (%) p-value 
Aspirin 73 (57) 53 (66) 0.24 
Lipid Lowering Agents 55 (43) 34 (43) 1.0 
Anticoagulants 30 (24) 17 (21) 0.74 
Antiplatelet Agents 36 (28) 34 (43) 0.049 
β-Blockers 75 (59) 50 (63) 0.66 
Calcium Channel Blockers 55 (43) 33 (41) 0.89 
Diuretics 17 (13) 16 (20) 0.24 
ACE Inhibitors/ARBs 51 (40) 36 (45) 0.56 
Digitalis 9 (7) 7 (9) 0.79 
Nitrates 18 (14) 11 (14) 1.0 
Inotropic Agents 1 (1) 1 (1) 1.0 
ACE = angiotensin converting enzyme; ARB = angiotensin receptor blocker; CABG = coronary artery  
bypass grafting. 
Table 3. Postoperative complications (N = 207). 
Complication Black n (%) White n (%) p-value 
MI 0 (0) 1 (1) 0.39 
Stroke 2 (2) 1 (1) 1.0 
ARDS 1 (1) 1 (1) 1.0 
Pneumonia 3 (2) 2 (3) 1.0 
GI Event * 4 (3) 4 (5) 0.71 
* Includes GI bleed, pancreatitis, cholecystitis, mesenteric ischemia, and other GI events. ARDS = acute 
respiratory distress syndrome; GI = gastrointestinal; MI = myocardial infarction. 
Kaplan-Meier survival curves for HD patients by race (Figure 1) were significantly different  
(p = 0.020; median survival: black = 4.3 years, white = 2.8 years). A total of 69 (50%) black patients 
and 30 (34%) white patients were censored. The unadjusted HR for white race was 1.6 (95% CI =  
1.1–2.3) (Table 1). After adjustment for age, sex, hypertension, CAD severity, heart failure, and prior 
stroke, the HR was 1.9 (95% CI = 1.2–2.8). The multivariable result did not substantively change with 
the pairwise addition of other variables listed in Tables 1 and 2. Approximately 87% of our patients 
were 50 years of age or older. Among this group, the adjusted HR remained statistically significant 
(HR = 1.6, 95% CI = 1.05–2.6, p = 0.029). 
Figure 1. Unadjusted Kaplan-Meier 5-year survival (N = 207). 
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3.2. Discussion 
Our results demonstrate a survival disadvantage for white HD patients after CABG, which is 
consistent with the general HD population. To the best of our knowledge, this is the first study to 
report this finding among HD patients receiving CABG. In contrast, a study of HD patients after heart 
valve replacement did not observe a survival difference by race (HR = 1.01, 95% CI = 0.95–1.09) [14]. 
The conflicting results may be due to demographic differences. For example, a higher percentage of 
patients in our study were black (39% vs. 31%) and above age 45 (93% vs. 80%) compared with  
the above study. Differences in inclusion/exclusion criteria, patient acuity, operative procedure,  
comorbid conditions, and in-hospitalization deaths also could explain the inconsistent findings 
between the studies. 
Reverse epidemiologic findings are commonly reported in the HD literature [15–18]. For example, 
white HD patients are more likely to die sooner than black HD patients. We observed a similar reverse 
finding among HD patients following CABG, even though risk factor profiles were similar between 
blacks and whites for the variables presented in Table 1. This differs from the general CABG 
population in which whites observe a survival advantage [19,20]. Explanations for this finding may 
include differences in genetics, nutritional status, inflammation, and sensitivity to dialysis [17,21].  
The latter factors were not included in the current study. Nonetheless we cannot rule out the possibility 
that the above mentioned survival paradox observed in our study reflects the observational nature of 
epidemiologic studies [6]. Retrospective cohort studies are excellent for the generation of hypotheses, 
however, they are unable to prove causality. Alternatively, the reverse epidemiologic effects may be 
due to residual confounding, inappropriate adjustment, or Simpson’s Paradox. 
3.3. Strengths and Limitations 
The current study is strengthened by its comparatively large sample size and long-term follow-up. 
Furthermore, we were able to accurately determine time of death using a combination of the National 
Death Index and our comprehensive electronic medical record. 
The retrospective design of our study may have introduced selection bias. Although we adjusted for 
known clinically relevant variables, we acknowledge that other unmeasured factors could have 
influenced the results due to the retrospective nature of the study. The status of several variables may 
have changed over time. We did not adjust for these variables in a time-dependent manner due to their 
potential to be in the causal pathway. Postoperative complications were not included in our analysis 
because of their time-dependent status. Also, status of revascularization (incomplete vs. complete) was 
not included due to inconsistencies in the definition of this variable [22]. 
Racial identify was self-reported and this could have resulted in misclassification bias. Furthermore, 
race may reflect cultural identification rather than genetic identity and this distinction was beyond the scope 
of our study. Cause of death is not recorded in the National Death Index and patients’ mortality could have 
had little to do with their heart disease and also could have contributed to misclassification bias. 
Higher body mass index has been associated with a lower in-hospital mortality risk among heart 
failure patients [23]. The number of underweight HD patients in our sample was small and we were 
unable to perform a similar comparison. Nonetheless, HD patients who were underweight had a greater 
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risk of mortality than those who were obese (HR = 2.1, 95% CI = 0.64–6.9), although the confidence 
interval was wide and spanned unity. 
Patients in this study were recruited over a relatively long period, over which patient characteristics, 
practice methods, and clinical care may have changed considerably. We did not account for patients 
who were previously on peritoneal dialysis or who were switched from HD any time after surgery. 
Also, the duration of dialysis and the acute versus chronic nature of their kidney disease was not 
recorded and this has been shown to influence survival [17]. We did not adjust our model for cause of 
CKD because the majority of patients had similar etiology (hypertension, diabetes, and obesity) [24]. 
HD patients with off-pump CABG have been shown to have better survival compared with  
on-pump procedures [5]. No distinction was made between these operations and long-term survival 
after CABG due to the small number of off-pump cases (n = 25). The results also are from a single 
center that may not generalize to the overall population. 
Recently, it has been suggested that the commonly cited increased mortality risk observed for white 
HD patients applies only to older adults [16]. Less than 15% of the 207 HD patients in our study  
were under the age of 50 and consequently we were limited in our ability to directly address this  
question. However, among elderly patients in our sample we observed a slight decrease in effect size  
(white vs. black, adjusted HR = 1.6) compared with the overall sample (white vs. black, adjusted  
HR = 1.9), suggesting that the increased risk of mortality for white vs. black patients also holds among 
younger patients. This is supported by a recent study, which reported that the survival advantage of 
black patients holds for age groups above 30 years of age [25]. However, we cannot rule out potential 
effect modification by age in our study due to our limited sample size. 
Our use of quartile boundaries, while desirable for minimizing the influence of outliers, may have 
yielded overly broad categories and the potential for residual confounding. However, the substitution 
of continuous variables in our models did not materially alter results. Additionally, multivariable  
Cox regression models, rather than propensity score matching, were used to control for  
confounding because of potential “non-collapsibility bias” inherent to logistic regression-based 
propensity scores [26]. 
Data regarding socioeconomic position, education, and income also were not collected in our study 
and these factors may have influenced survival [27]. For example, factors related to socioeconomic 
position, historic discrimination, and related comorbidities could have influenced which patients were 
selected to receive surgery. Twenty-eight (97%) of the 29 counties in eastern North Carolina fall below 
the national per capita income of $27,915, with half reporting a value less than $20,000 [28]. Similarly, 
90% of the counties have a higher percentage of blacks than the national value of 13.1% [28]. 
Selection bias also could have been due to related socioeconomic factors such as lack of insurance 
coverage, transportation, and overall poor health status. We were unable to reliably estimate 
socioeconomic position using zip codes because a large percentage of patients in our region live in 
rural areas with postal box addresses.  
4. Conclusions  
White HD patients were observed to have worse survival following CABG than black HD patients. 
This effect is paradoxically reversed from the general non-HD population. The findings of this study 
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have important implications for identifying at-risk HD patients who may require early preoperative 
intervention and close postsurgical follow-up. Further studies with larger sample sizes are needed to 
confirm our findings and to explore the underlying causes of this potential racial difference in survival 
among HD patients. 
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